RetaNord sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are not for human or veterinary use and have not been evaluated by the European Medicines Agency or any other regulatory authority.

GHRH analogue + GH secretagogue
This is a paired research blend of CJC-1295 (a growth-hormone-releasing-hormone analogue) and Ipamorelin (a selective growth-hormone secretagogue), commonly studied together as a complementary GH-axis research pair.
Both kit sizes ship within the EU — free shipping either way.
Plain, unbranded packaging. No product names, no logos — nothing on the outside indicating what is inside. Tracked to a DPD Locker or your address.
Guaranteed delivery. If your order doesn't reach you, we ship it again free — lost, damaged or stolen.
For laboratory and in vitro research use only. Not for human or veterinary use, and not for use in diagnostic procedures.
CJC-1295 is a synthetic analogue of growth-hormone-releasing hormone (GHRH); Ipamorelin is a selective growth-hormone secretagogue (a GHRP). The two act on complementary parts of the growth-hormone axis and are frequently studied together, so RetaNord supplies them as a combined 10-vial research kit. The 10 mg is the combined peptide mass per vial.
RetaNord supplies CJC-1295 / Ipamorelin as fixed kits of 10 or 30 lyophilized vials, each verified at 99%+ identity purity by independent third-party HPLC (Janoshik), and every kit ships with a lot-specific Certificate of Analysis. Supplied for laboratory and in vitro research use only.
Two peptides acting on different receptors of the same axis. CJC-1295 is a stabilised analogue of growth-hormone-releasing hormone, acting at the GHRH receptor. Ipamorelin is a selective agonist at the ghrelin / growth-hormone-secretagogue receptor — a different receptor entirely.
Because the two inputs converge on the same pituitary output through separate routes, they are routinely studied together. Ipamorelin is described in the founding literature as selective: unlike earlier secretagogues it was reported not to raise cortisol or prolactin at effective doses.
Mechanistic summary drawn from published literature, provided for research context only. Not a therapeutic claim.
The 1998 European Journal of Endocrinology paper introduced ipamorelin as the first selective growth-hormone secretagogue; a 2006 JCEM study reports prolonged GH and IGF-I stimulation with CJC-1295.
A note on naming: “CJC-1295” is used for two different molecules in circulation — the version with a drug-affinity complex (DAC) and the shorter modified GRF(1–29) without it. Check the lot documentation rather than assuming which one a supplier means.
An educational summary of published literature. It is not a claim about any outcome for any buyer, and RetaNord supplies this compound for laboratory research use only.
Sealed, lyophilized vials. 2–8 °C for routine storage; −20 °C or below for long-term. Room temperature is for transit and handling only — it is not a storage state for a peptide.
Once reconstituted. Keep at 2–8 °C and never freeze — ice crystals cause irreversible damage. Reconstituted with bacteriostatic water (0.9% benzyl alcohol) a vial is commonly used within about 30 days; with plain sterile water, within 24–48 hours.
Keep vials sealed and protected from light, and minimise freeze–thaw cycles of frozen stock — each cycle costs potency.
Work out concentration and draw volume in the reconstitution calculator →
| Category | Growth Hormone |
|---|---|
| Compound class | GHRH analogue + GH secretagogue blend |
| Presentation | 10 vials per kit · lyophilized |
| Available sizes | 10 mg per vial |
| Constituent peptides | CJC-1295 (GHRH analogue) + Ipamorelin (GH secretagogue) · combined mass per vial |
| Physical form | Sterile-filtered, freeze-dried |
| Identity purity | 99%+ (HPLC) |
| Independent testing | Janoshik · third-party HPLC |
| Storage | 2–8°C; −20°C long term |
| Documentation | Lot-specific Certificate of Analysis |
Certificate of Analysis — batch VJ551537Independent third-party testing by Janoshik · HPLC purity 99.558% and content verified.View the full report →Selected peer-reviewed literature via PubMed, provided for educational context. A reference does not imply a clinical claim for RetaNord products.
Yes — every kit ships with a lot-specific third-party Certificate of Analysis: independent HPLC purity and content testing by Janoshik, with the batch matching your vials. View the current CoA.
CJC-1295 (a GHRH analogue) and Ipamorelin (a GH secretagogue) act on complementary points of the GH axis and are commonly studied as a pair. The vial contains both. Supplied for laboratory research use only.
These research compounds are supplied in fixed kits of 10 identical vials — the standard research quantity. One kit (10 vials) is the minimum order to the EU.
Sealed lyophilized vials keep at 2–8 °C, or −20 °C for long-term storage. Once reconstituted, keep refrigerated and never freeze it. See storage & handling for the full detail.
The volume of bacteriostatic water you add sets the concentration — the vial size alone does not. Enter your vial size and diluent volume in the reconstitution calculator to calculate the concentration for your assay.
“CJC-1295” is used in the market for two molecules: the DAC version and modified GRF(1–29) without DAC. Check the lot-specific Certificate of Analysis for what is in your batch, or ask us before ordering if it matters to your protocol.
Every RetaNord kit ships within 24–48 hours, discreetly packaged and tracked. All kits ship within the EU. For laboratory research use only.
Order this kitA person answers every message — the same day, seven days a week.